Vaxxinity Total Liabilities

The latest total liabilities for VAXX is $31M as of December 2023. That compares with $44M in the prior-year period — down 30.0% year over year. Investors often review this figure alongside Vaxxinity's historical trend and sector peers before judging valuation or financial health.

Over the past year, VAXX's total liabilities moved from $44M to $31M — a 30.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Vaxxinity's operating scale or balance-sheet position.

A total liabilities figure of $31M for VAXX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting VAXX's total liabilities ($31M), review year-over-year change from $44M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.